CurifyLabs

CurifyLabs: Automated compounding technology for personalized medicines in pharmacies and hospitals. HealthTech · Series A · Helsinki, Finland. Rated 70/100…

Automated compounding technology for personalized medicines in pharmacies and hospitals.

Preliminary profile · public data only

Startup24 listed CurifyLabs from public information on the company's own website; its founders have not claimed or verified the profile yet. The rating below is preliminary, based on public data only, and is an opinion — not investment advice. Founders can claim the profile, and anyone can report an error or request removal, on this page.

At a glance

• Category: HealthTech (Personalized medicine compounding automation)
• Stage: Series A
• Location: Helsinki, Finland

Startup24 rating: 70/100

CurifyLabs has a differentiated, integrated compounding platform with reported clinical use in Europe and the US, supported by a pharmacist-led team and $14 million raised.

About the rating

Every startup on Startup24 is scored on the same six criteria — team, market, product, advantages, risk and reputation — with the reasoning written out. Founders list for free; investors subscribe to see the full analysis.

• How the score is calculated
• Browse the catalogue

Startup24 (startup-24.com) rates startups on real, verified data: founders list for free, investors subscribe to find them first. Operated by DOTOVO OÜ, Tallinn, Estonia.